Photodynamic Therapy With Verteporfin (Visudyne) For Macular Degeneration
Photodynamic therapy with verteporfin (Visudyne--CIVA Vision), an injectable drug, is now being used for treatment of age-related macular degeneration. The drug is a benzoporphyrin derivative that, when activated by light in the presence of oxygen, generates highly reactive radicals that damage neovascular endorthelium and occlude the vessels....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Photodynamic Therapy With Verteporfin (Visudyne) For Macular Degeneration
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1086
Article Code: 1086c
Date: September 4, 2000
Volume: 42
Pages: 81-82
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1086
Article Code: 1086c
Date: September 4, 2000
Volume: 42
Pages: 81-82
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)